Multiple myeloma begins when abnormal cells multiply and grow uncontrollably in a person’s bone marrow, crowding out healthy ...

Gilead Sciences has entered into an option and license deal with Kymera Therapeutics to support the development and sales of ...

Thousands of women battling advanced breast cancer could be denied access to crucial life-extending medication due to an ...

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

A potential treatment for glioblastoma crafted by scientists at The Wertheim UF Scripps Institute renders the deadly brain ...

A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

Many — but not all — of the 21 drugs studied caused mutations and premature ageing in healthy blood, the researchers found. One three-year-old patient being treated for a nerve tissue cancer had more ...

A new cancer drug candidate developed by Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and ...

EXCLUSIVE: Skin cancers can be among the most aggressive forms of the disease so using drugs to shrink them must be used with precision.